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Background: Molecular techniques that detect canine lymphoma cells by their clonal antigen receptor gene
rearrangement play an increasing role for diagnosis as well as for monitoring minimal residual disease during
and after cytostatic therapy. However, the methods currently available are time-consuming and/or cost-intensive
thus impeding the use in clinical routine. The aim of the present study was to develop and evaluate a real-time
polymerase chain reaction (PCR) with subsequent melting curve analysis (MCA) for the detection of clonally
rearranged antigen receptor genes in dogs with B and T cell lymphoma on non formalin-fixed and paraffin-embedded
lymph node samples.
Results: In lymph node aspirates from 30 dogs with multicentric B cell lymphoma, real-time PCR with MCA detected
clonal rearrangement in 100% and conventional PCR with polyacrylamide gel electrophoresis (PAGE) in 93% of
samples. Both methods correctly identified clonality in 80% of lymph node aspirates of 10 dogs with T cell
lymphoma. None of the two PCR systems detected clonal rearrangement in samples from 9 dogs with lymph
node hyperplasia. Using a dilutional series with regular lymphoid desoxyribonucleic acid (DNA), detection
limits of lymphoma DNA were as low as 0.8% and 6.25% for B and T cell clonal rearrangement with real-time PCR and
MCA and at 3.13% and 12.5% with the conventional system. Median absolute detection limits of lymphoma DNA were
shown to be at 0.1 ng and 1 ng for the B and T cell immunophenotype with the real-time PCR system and at 10 ng
each with conventional PCR and PAGE.
Conclusions: Real-time PCR with MCA is a convenient and reliable method with a good analytical sensitivity. Thus, the
method may assist the detection of clonal antigen receptor gene rearrangement in canine lymphoma patients in a
clinical setting also in the presence of small amounts of neoplastic cells.
Keywords: Lymphoma, Dog, Real-time polymerase chain reaction, Melting curve analysis* Correspondence: K.Langner@gmx.de
1Small Animal Clinic, University of Veterinary Medicine, Buenteweg 9, 30559
Hannover, Germany
Full list of author information is available at the end of the article
© 2014 Langner et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Langner et al. BMC Veterinary Research 2014, 10:1 Page 2 of 11
http://www.biomedcentral.com/1746-6148/10/1Background
Lymphoma is one of the most common hematopoetic
malignancies in dogs [1,2]. Detection of large amounts
of tumor cells is reliably achieved by standard diagnostic
methods such as cytology and flow cytometry [3-5]. The
assessment of small cell numbers, however, requires highly
sensitive molecular-based assays that detect lymphoma
cells by their clonal rearrangement of the antigen receptor
[6]. Within the past years, polymerase chain reaction
(PCR) techniques have been successfully established for
molecular staging of lymphoma patients as well as for the
evaluation of minimal residual disease (MRD) during and
after chemotherapy [7-10].
Current PCR strategies in canine lymphoma include a
conventional system that utilizes universal primers for
the amplification of the clonally rearranged third com-
plementarity determining region (CDR3) of the antigen
receptor and subsequent polyacrylamide gel electrophor-
esis (PAGE) for the analysis of PCR products [6,7].
Moreover, a probe-based real-time PCR assay has been
developed using allele-specific primers, probes and
standard curves, enabling a highly sensitive detection of
canine lymphoma cells by their individually rearranged
CDR3 [8]. Despite their sensitivity, both assays impede
the widespread use in clinical routine: Conventional
PCR systems with PAGE are time-consuming and have a
risk of carry-over contamination due to the need of
post-PCR processing of samples. Recent use of capillary
electrophoresis instead of PAGE circumvented these
issues [11,12] but the method is not yet standard equip-
ment in veterinary research. Probe-based real-time PCR
requires high technical experience as well as a labour- and
cost-intensive individual set-up with CDR3 specific primers
for each patient.
Real-time PCR methods with subsequent melting curve
analysis (MCA) using universal primers and fluorescent
dyes have been successfully applied in malignant lympho-
proliferative neoplasias in humans such as acute and
chronic lymphocytic leukaemia, non-Hodgkin’s lymphoma
and cutaneous T cell lymphoma [13,14]. The assays have
been shown to be both specific and sensitive for diag-
nostic purposes as well as for monitoring MRD. Fol-
lowing the amplification reaction, MCA is carried out
in the same vessel by gradually raising the temperature.
Specific melting temperatures of the amplicons (Tm),
determined by their individual length, sequence, G:C
content and Watson-Crick base pairing are displayed
as peaks by plotting the negative first derivative of the
fluorescence versus the temperature [15]. Clonal sam-
ples containing large amounts of a single PCR product
appear as tall, distinct and symmetrical peaks on MCA,
whereas non-neoplastic lymphoid samples, resembling
small amounts of several different amplicons, present
as flat, wide and/or irregular peaks.Therefore, we hypothesized that real-time PCR with
MCA would be a specific and sensitive method to obtain
molecular data for canine lymphoma patients in an eco-
nomical way. In the current study, we evaluated a newly
developed real-time PCR system with MCA in compari-
son to a conventional PCR method with PAGE for the
detection of clonal antigen receptor gene rearrangement




Forty dogs presented for clinically and cytologically
confirmed multicentric lymphoma at the Small Animal
Clinic, University of Veterinary Medicine Hannover,
Germany, between 2008 and 2012 were enrolled in the
study. Further inclusion criteria were clinical staging
according to the World Health Organization staging
system for domestic animals [16] with thoracic and ab-
dominal radiographs, abdominal ultrasound, cytological
assessment of aspirates from liver, spleen and bone mar-
row. Moreover, determination of the immunophenotype
and application of combination chemotherapy [17] were
required for enrollment. Patients that had received
cytostatic therapy or immunosuppressant drugs for any
reason were excluded from the study. Seventeen of the
dogs were females (10 spayed) and 23 were males (8 cas-
trated). Dogs were between 1 and 16 years (mean 7
years). The following breeds were included: mixed breed
(7), Bernese Mountain Dog (6), Rottweiler (4), Cocker
Spaniel (2), Small Munsterlander (2), Labrador Retriever
(2), Golden Retriever (2), Boxer (2), Beagle (1), Norwich
Terrier (1), Pug (1), Bullmastiff (1), Border Collie (1),
Dachshound (1), Hovavart (1), Miniature Schnauzer (1),
English Setter (1), Shetland Sheepdog (1), Australian
Shepard (1), Old German Shepard (1) and West Highland
White Terrier (1).
Six of the dogs were classified as clinical stage III, 21
dogs as stage IV and 13 dogs as stage V. Fifteen dogs
had substage a and 25 dogs had substage b. Immuno-
phenotyping using flow cytometric analysis of lymph
node aspirates was performed as described previously
[18] and revealed lymphoma of the B and T cell pheno-
type in 30 and 10 cases, respectively.
Lymph node samples of 9 dogs with cytologically con-
firmed lymph node hyperplasia served as the polyclonal
control. A total of 12 lymph node samples containing
regular lymphoid tissue was obtained from freshly eutha-
nized dogs and was used for the polyclonal control with
real-time PCR as well as for the dilutional series of
lymphoma DNA with regular lymphoid DNA.
The study design was reviewed and approved by the
Ethics Committee for Animal Experiments of Lower
Saxony, Germany (33.9-42502-05-07A512). Written owner
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Sample preparation
Lymph node aspirates or biopsies were obtained from
dogs with and without lymphoma and stored at −70°C
until used for desoxyribonucleic acid (DNA) extraction.
Sampling sites included the cervical, popliteal or sternal
lymph nodes. A total of 2 samples were taken per site.
The first sample was used for cytology and flow cytome-
try (needle flushed with medium to obtain remaining
cells). The second sample was subjected to DNA extrac-
tion using the DNeasy extraction kit (Qiagen, Hilden,
Germany) according to the manufacturer’s instructions.
Concentration and purity of DNA preparations was de-
termined on a spectrophotometer (Eppendorf, Hamburg,
Germany).
Conventional PCR and PAGE
Polymerase chain reaction was performed on lymphoid
DNA using 2 sets of primers for the assessment of clonal
rearrangement of the immunoglobuline heavy chain
(IgH major and minor, B cell lymphoma) and 1 set for
the detection of rearranged T cell receptor γ locus
(TCRγ, T cell lymphoma) as previously described [6].
Amplification of the constant region gene of immuno-
globuline M (Cμ) was performed on all samples to
ensure quality of lymphoid DNA. All samples were ana-
lyzed in duplicates with all 4 sets of primers including a
non-template control for each run. Briefly, samples were
heated for 15 min at 94°C followed by 35 cycles of 8 sec
at 94°C, 10 sec at 60°C and 15 sec at 72°C. Initially, a
total of 100 ng of DNA were used per reaction. If no
band was detected, an increased amount of 500 ng of
DNA was used. Amplicons were subsequently subjected
to PAGE on 12.5% native polyacrylamide gels. Gels were
stained with GelRed (Biotium, Hayward, CA), and bands
were visualized on a Bio-Vision imaging system (Vilber
Lourmat, Marne La Vallee, France). Evaluation for clonal
antigen receptor gene rearrangement was done as previ-
ously described in dogs with lymphoma [6]. Briefly,
single or few distinct bands were indicative for clonal
antigen receptor gene rearrangement whereas a smear
or several faint bands were consistent with the absence
of lymphoma cells in the sample. Abscence of pseudo-
clonality was determined by similar size of bands on
duplicate samples.
Real-time PCR and MCA
Amplification and subsequent MCA were run in 96-well
optical reaction plates (Applied Biosystems, Darmstadt,
Germany) using a StepOnePlus amplification and detec-
tion system (Applied Biosystems). A standard reaction
mixture contained 100 ng of sample DNA, one set ofprimers and the SYBR Green I PCR master mix (Applied
Biosystems) at a total volume of 25 μl. All samples were
analyzed with all 4 primer sets. Samples were run in
triplicates to reduce risk of false positive or false negative
results due to technical errors. Pseudoclonality was ruled
out by identical Tm and superimposable peaks on tripli-
cate analysis. A total of 100 ng of sample DNA was used
per reaction. For each run a clonal control consisting of
lymphoma DNA, a polyclonal control of regular lymph-
oid DNA, and a non-template control were included.
Preincubation was performed for 10 min at 95°C
followed by 30–60 cycles of 15 sec at 95°C for denatur-
ation and 45 sec at 60°C for annealing and extension.
Fluorescence was measured at the end of each cycle.
After completion of amplification, MCA was performed
by gradually raising the temperature by 0.3°C/sec to 95°C
during continous fluorescence monitoring. Negative
first derivative of the fluorescence was plotted versus
the temperature at the individual Tm of the amplicon to
obtain easily assessable melting peaks [15]. All fluorescent
reporter signals were measured against the internal refer-
ence dye (ROX) signal to normalize for non-PCR related
fluorescence fluctuations between wells. Data were analyzed
using the StepOne v2.0 software (Applied Biosystems).
Evaluation of clonal rearrangement was done as previously
described for human lymphoproliferative neoplasias [13,19]
and was represented by a distinct symmetrical peak on
MCA whereas regular lymphoid or hyperplastic tissue
appeared as flat, irregular and/or wide peaks. To establish a
reliable diagnosis of clonality, different primer concentra-
tions using lymphoma DNA and non-template control
were tested according to the manufacturer’s instructions.
Finally, the peak height (−d[F1]/dT) ratio between sample
and regular lymphoid DNA was optimized by adjusting the
starting point of MCA and the number of amplification
cycles [20-22].Determination of detection limit
Logarithmic serial dilutions of lymphoma samples with
water (100 to 0.01 ng) and 2-fold dilutional series with
regular lymphoid tissue (50% to ~0.4% of lymphoma
DNA) were subjected to analysis by conventional and
real-time PCR. Depending on the previously determined
type of rearrangement, corresponding primer sets for ei-
ther B or T cell analysis were chosen. Samples were run
in duplicates with conventional PCR and in triplicates
with real-time PCR for each dilutional step. The regular
lymphoid DNA used for the dilution was a mix of 12
samples of the 3 dogs without cytological lymph node
abnormalities. The mixture was prepared to adjust for
potential variations between individual samples. Limit of
detection was defined as the last concentration produ-
cing a visible band on PAGE or distinct peak with MCA.
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Specificity and sensitivity for real-time PCR with MCA
in comparison to the conventional PCR system were
calculated according to the method of Gerstman and
Cappucci [23].
Results
Establishment of real-time PCR with MCA
Real-time PCR carried out with the same primer
concentrations and numbers of amplification cycles as
conventional PCR revealed a single sharp peak in all
samples using the Cμ primer set whereas samples from
dogs with B and T cell lymphoma had distinct large
peaks with the corresponding primer sets IgH major,
minor and TCRγ (Figure 1). The amplification of regular
lymphoid DNA showed irregular peaks of smaller sizes.
With both real-time PCR and conventional PCR the
same loci were found clonally rearranged.
In a first optimization step, primer concentrations
revealing the highest signal intensity were identified
(Table 1).
Subsequently, starting temperature of MCA was set at
78°C for IgH major and minor and at 75°C for TCRγ as
it reduced analysis time and peak height of the poly-
clonal control compared to the clonally rearranged
samples.
Finally, a total of 50 cycles for IgH major and of 40
cycles for IgH minor and TCRγ was found to be optimalFigure 1 Evaluation of clonal rearrangement of canine lymphoma sam
(A) and T cell lymphoma (B) were amplified with 4 primer sets for lympho
clonality (TCRγ) by conventional and SYBR Green I real-time PCR. Clonal sam
on subsequent PAGE and MCA.for the differentiation between lymphoma samples and
non-neoplastic DNA based on the peak height of clonal
samples and the peak height ratio (Figure 2). The overall
peak height of non-neoplastic DNA was remarkably
lower when amplified with the IgH major than with IgH
minor (the latter not shown) and TCRγ primer sets.
Moreover, the peak height of the regular lymphoid sam-
ples showed a much greater variability with TCRγ than
with IgH major and minor. Differences of Tm between
regular lymphoid and lymphoma DNA were greater with
IgH major than with IgH minor and TCRγ primer sets.
Based on these settings, clonality of a sample was de-
fined by a –d(F1)/dT ratio from sample DNA to regular
lymphoid DNA of at least 1.5:1 for IgH major, 3:1 for
IgH minor and 2:1 for TCRγ. In addition, the shape of
the clonal peak had to be symmetrical. The peak height
was measured for both clonal and regular lymphoid
samples, from zero to the highest point of the melting
curve to ensure consistent evaluation.
Detection of clonal antigen receptor gene rearrangement
in clinical cases
A total of 49 lymph node samples (40 from dogs with
lymphoma, 9 from dogs with with lymph node hyperpla-
sia) were analyzed by conventional and real-time PCR
(Tables 2 and 3). Of the lymphoma samples, 30 were of
the B cell type whereas 10 were T cell lymphomas as
determined by flow cytometry. Internal control using Cμples by PAGE and MCA. Samples of dogs with B cell lymphoma
id DNA control (Cμ), B cell clonality (IgH major and minor) and T cell
ples concordantly revealed single sharp bands and distinct tall peaks
Table 1 Real-time PCR reaction conditions
Product Primer Amplification conditions
Name* Amount per
reaction (nM)


















*Primer names and sequences according to Burnett et al. [6].
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DNA quality and integrity in all preparations by both
PCR methods.With the conventional PCR system, the B
cell immunophenotype was identified in 93% of samples
of dogs with lymphoma (28/30: 23 IgH major, 2 IgH
minor, 3 IgH major and minor) and the T cell type in
80% of samples (8/10). Most samples revealed positive
results using a total amount of 100 ng of DNA whereas
some required an increase of DNA to 500 ng per reac-
tion. Samples of 4 dogs with lymphoma (2 with B and T
cell lymphoma each) failed detection of clonal rearrange-
ment with the increased DNA amount per reaction.
Real-time PCR and MCA revealed B cell clonal re-
arrangement in 100% of lymphoma cases (25 IgH major,
2 IgH minor, 3 IgH major and minor) and the T cell type
in 80% of cases (8/10). The Tm was 82.67°C ±1.22 for
IgH major, 81.86°C ± 0.46 for IgH minor and 78.74°C ±
0.66 for TCRγ. Samples of 2 patients with T cell lymph-
oma revealed a large symmetrical double-peak with
MCA. Gel electrophoresis of these samples showed 2
similar distinct bands for each sample, thus the corre-
sponding samples were classified as clonal. The same 2
patients with T cell lymphoma that were missed with the
conventional method failed to show clonal rearrange-
ment with the real-time system. The 2 dogs with B cell
lymphoma that were missed by conventional PCR and
PAGE revealed smaller peak heights on MCA with IgH
major than other samples (Figure 3B) although quality
of lymphoid DNA was comparable (Figure 3A).
Samples that were identified by both PCR methods
revealed clonal rearrangement of the same loci. None of
the two PCR methods detected clonal rearrangement in the
9 samples with lymph node hyperplasia. With conventional
PCR and PAGE, results remained negative even if increased
amounts of DNA of 500 ng per reaction were used. With
MCA, peak height and peak shape of hyperplastic samples
was comparable to the polyclonal control (data not shown).Limit of detection of clonal antigen receptor gene
rearrangement
The detection limit for clonal rearrangement was deter-
mined for conventional and real-time PCR using dilu-
tional series of lymphoma samples with water and with
regular lymphoid DNA.
Logarithmic dilutions into water ranging from 100 ng
to 0.01 ng were prepared of 6 samples each with IgH
major, minor and TCRγ clonality. Analysis of the dilu-
tional series by conventional PCR and PAGE revealed
visible bands to a concentration of 0.3 ng (median
10 ng) with IgH major, to 10 ng (median 30 ng) with
IgH minor and to 3 ng (median 10 ng) with TCRγ. With
real-time PCR and MCA, clonal rearrangement was
demonstrated to 0.1 ng (median 0.1 ng), 1 ng (median
3 ng) and 0.3 ng (median 1 ng) with IgH major, minor
and TCRγ.
To evaluate the detection limit for clonal rearrange-
ment in the presence of non-neoplastic lymphoid tissue,
2-fold dilutional series (50% to ~0.4% of lymphoma
DNA) were prepared of 12 samples with IgH major
clonality and of 6 samples each of IgH minor and TCRγ
clonality (Figure 4). Conventional PCR showed positive
results to 3.13% (median 12.5%) of lymphoma DNA with
IgH major and minor and to 12.5% (median 25%) with
TCRγ. Real-time PCR revealed detection of clonal
rearrangement to 0.78% (median 9.38%), 3.13% (median
12.5%) and 6.25% (median 18.5%) of neoplastic DNA
with IgH major, IgH minor and TCRγ, respectively. The
total number of samples showing clonal rearrangement
at the lower concentrations of lymphoma DNA was
higher for real-time PCR than for the conventional
method (Figure 5).
Discussion
Real-time PCR with MCA is used in various human
lymphoid neoplasias for the diagnosis of clonal antigen
receptor gene rearrangement by its characteristic pattern
on MCA [13,14,19-22,24-26]. The method enables a
reliable differentiation between neoplastic and regular
lymphoid tissue with a minimum of hands-on time. The
present study describes the development and evaluation
of a real-time PCR with MCA for the detection of ca-
nine lymphoma using previously established primer sets
[6]. The method was assessed in comparison with a con-
ventional PCR system, utilizing a total of 40 lymph node
aspirates from dogs with B or T cell lymphoma and a
total of 9 samples of dogs with lymph node hyperplasia.
The real-time PCR system used in the present study re-
vealed a similar pattern on MCA for lymphoma samples
as described for human lymphoproliferative neoplasias.
Based on the tall and symmetrical shape of the peaks, all
samples with the exception of 2 dogs with T cell lymph-
oma showing flat and irregular peaks, would have been
Figure 2 Optimization of real-time PCR and MCA for the detection of B and T cell clonal rearrangement. Samples of 3 dogs with B cell
lymphoma (A, grey lines) and T cell lymphoma (B, grey lines) were amplified in parallel with regular lymphoid DNA from 3 dogs (black lines) for
30, 40 and 50 cycles. A total of 50 cycles for IgH major and of 40 cycles for TCRγ were found to be optimal for evaluation of clonal rearrangement, based
on the peak height of clonal samples and the –d(F1)/dT ratio between lymphoma and non-neoplastic DNA. Peak height was measured for all samples
from zero to the highest point of the melting curve.
Langner et al. BMC Veterinary Research 2014, 10:1 Page 6 of 11
http://www.biomedcentral.com/1746-6148/10/1correctly identified. Some studies in human medicine ex-
clusively utilized the presence of a symmetrical peak for
diagnosing clonal rearrangement [13,14,19]. However,
this method is difficult to standardize. In the present
study we used an optimized ratio of the peak height
between lymphoma and regular lymphoid DNA as an
additional criterion to the peak shape, as previously
described for human T and B cell neoplasias [20-22,26].
Since the peak height not only relies on the clonality but
also on the amount of DNA in the sample, the use ofidentical amounts of DNA in both sample and regular
lymphoid control is warranted to obtain reliable results.
Moreover, although real-time PCR system as described
in the present study enables facilitated interpretation of
clonality results to some degree, it may become necessary
in certain applications (e.g. high polyclonal backgrounds
in MRD) to adjust the cut-offs accordingly.
The real-time PCR and MCA revealed comparable
sensitivity and specificity to the conventional PCR sys-
tem with PAGE. The results are in concordance with
Table 2 Clonal antigen receptor rearrangements by
conventional and real-time PCR in dogs with B cell
lymphoma* (n = 30)
Conventional PCR
Rearranged Not detected Total
Real time PCR
Rearranged 28 2 30
Not detected 0 0 0
Total 28 2 30
*as determined by flow cytometry.
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relative sensitivities of 100% and specificities of 97% to
100% for MCA compared to PAGE [20,22]. In the
present study, 2 dogs with B cell lymphoma detected by
the real-time PCR system were missed by conventional
PCR with PAGE (Figure 3). The low peak height on
MCA following the amplification with IgH major com-
pared to other samples may be suggestive of a reduced
amount of clonally rearranged DNA in these samples.
According to the peak heights seen for Cμ, it can be
assumed that the quality of lymphoid DNA was compar-
able to other samples. It may be concluded, that real-
time PCR with MCA was more capable of detecting
small amounts of clonally rearranged DNA than conven-
tional PCR with PAGE. However, as capillary electro-
phoresis has been proven superior to PAGE for the
resolution of clonally rearranged DNA in dogs with
lymphoma [11,12], the use of this method may have
improved the sensitivity of the conventional system.
Comparison of MCA to PAGE in human B and T cell
malignancies showed an improved detection limit for
dilutions of lymphoid DNA [13,20,22,26]. Overall detec-
tion limits for MCA ranged between 0.25% and 12.5% of
neoplastic DNA for B cell clonality, and 6.25% to 10%
for T cell clonality. The limits were up to 4-fold higher
than for conventional PCR [26]. In the present study,
the lower detection limits for IgH major and TCRγ were
4- and 2-fold higher for MCA compared to PAGE, thus
indicating an increased analytical sensitivity of the real-
time PCR. However, as above, the use of conventionalTable 3 Clonal antigen receptor rearrangement by
conventional and real-time PCR in dogs with T cell
lymphoma* (n = 10)
Conventional PCR
Rearranged Not detected Total
Real time PCR
Rearranged 8 0 8
Not detected 0 2 2
Total 8 2 10
*as determined by flow cytometry.PCR with capillary electrophoresis as [11,12] may have
improved the detection limit in the present setting.
Real-time PCR with MCA failed to detect clonal re-
arrangement in samples of 2 patients with T cell lymph-
oma. The poor performance of PCR in the current
setting is likely due to the primer set used for the ampli-
fication of the canine TCRγ [27,28]. Simplex primer sets
as used in the present study can miss clonality in a mul-
ticassette structure like the canine TCRγ. This assump-
tion was supported by the failure of conventional PCR
and PAGE to detect clonal rearrangement in the same 2
patients. A recently developed multiplex PCR revealed a
markedly improved sensitivity for the detection of TCRγ
rearrangement compared to single primer sets [12] and
may also be applicable to real-time PCR with MCA. A
less likely explanation for the failure of detection in
these 2 cases may be the aspiration of lymphoid tissue
other than the neoplastic population. This cannot be
ruled out in the present study as the sampling process
involved one aspirate that was analyzed by cytology and
flow-cytometry and a second aspirate that was used for
DNA extraction and subsequent amplification without
prior microscopical assessment.
Detection limits of both PCR methods were inferior
for T cell clonality compared to samples of dogs with B
cell lymphoma. Similar findings have been described
previously in veterinary medicine [6]. Conventional PCR
and PAGE in a dog with B cell leukemia revealed clonal
rearrangement at concentrations as low as 1%, whereas a
dog with T cell neoplasia had a detection limit of 10% of
neoplastic DNA. Recently, detection limits of 5% using a
multiplex PCR and 1% using simplex assays were de-
scribed [12]. Detection of clonal products was partially
hampered by the polyclonal background caused by the
multicassette structure of TCRγ. Similarly, real-time
PCR with MCA revealed a markedly elevated polyclonal
background for TCRγ compared to IgH major and
minor (Figure 2A,B). In addition, differences in Tm be-
tween regular lymphoid DNA and lymphoma DNA were
smaller for the amplification with TCRγ than for IgH
major and minor. Both findings likely contributed to the
reduced detection limit of the real-time PCR system for
T cell lymphoma in the present study.
One limitation of the real-time PCR is the lack of
standardization of B and T cell DNA in samples of dogs
with and without lymphoma. A reliable comparison of
peak heights ideally requires similar amounts of either B
or T cell DNA in sample and control as a shift towards
one population may result in an inflation of the corre-
sponding melting peak. To avoid false positive results,
peak shape was established as a second criterion for
diagnosing clonal rearrangement. Thus, non-neoplastic
samples containing a higher amount of B or T cell DNA
than the control are likely to be identified as polyclonal
Figure 3 Evaluation of 3 patients with B cell lymphoma by MCA and PAGE. Samples of 3 dogs with B cell lymphoma were amplified with
Cμ (A) and IgH major (B) primer sets by real-time and conventional PCR. Amplification with Cμ primers revealed comparable peak heights on
MCA and distinct bands on PAGE for all dogs. Amplification with IgH major primers showed positive results for all 3 dogs on MCA, based on the
cut-off of 1.5:1 of lymphoma to regular lymphoid DNA although peak heights varied significantly. Two of the dogs revealing lower peak heights
on MCA (dogs 2,3) failed to show identifiable distinct bands on PAGE. All reactions were carried out with a total of 100 ng of DNA.
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Figure 4 Dilutional series of lymphoma DNA analyzed by conventional and real-time PCR. Lymphoma samples of a dog with B cell
lymphoma (A) and T cell lymphoma (B) were serially diluted into regular lymphoid DNA (rlDNA; 50%, 25%, 12.5%, 6.25%, 3.13%, 1.56%, 0.78%)
and amplified with IgH major and TCRγ primer sets. The minimal concentration producing a visible band was 3.13% and 12.5% for B and T cell
clonal rearrangement with conventional PCR and subsequent PAGE. The detection limit for real-time PCR with MCA was 1.5% and 6.25% for B
and T cell clonal rearrangement, based on the cut-off of a –d(F1)/dT ratio from sample DNA to regular lymphoid DNA of at least 1.5:1 for IgH
major and 2:1 for TCRγ. The regular lymphoid DNA was prepared as a mix of 12 lymph node samples of 3 dogs to adjust for peak height
variations between individual samples as observed for the amplification of regular lymphoid DNA with the TCRγ primer set (Figure 2B). Gel images
include one lane with 100% lymphoma DNA and a non-template control (NTC).
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A recent study investigating MRD in dogs with B cell
lymphoma revealed detection limits of 1 lymphoma cell per
10.000 non-neoplastic lymphoid cells [9]. IndividuallyFigure 5 Comparison of detection limits between conventional and r
lymphoma (A) and 6 dogs with T cell lymphoma (B) were prepared with r
and amplified with IgH major and TCRγ primer sets by both PCR methods.
and MCA (white squares) is indicated for each concentration.designed primers, standard curves and probes targeting the
CDR3 region were utilized for the evaluation. By contrast,
in the present study, universal primers were used that amp-
lify both, neoplastic and regular lymphoid DNA, thereby
reducing the overall sensitivity of the method for theeal-time PCR. Serial dilutions of DNA samples of 18 dogs with B cell
egular lymphoid DNA (50%, 25%, 12.5%, 6.25%, 3.13%, 1.56%, 0.78%)
The number of positive results obtained with PAGE (black squares)
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when small amounts of tumor cells and large amounts of
non-neoplastic lymphoid cells are expected as in MRD.
However, MRD was detected with universal primers in the
peripheral blood of dogs with lymphoma that were in
complete remission using conventional PCR with
PAGE [29]. Therefore, detection of MRD by real-time
PCR and MCA in combination with universal primers
may be possible.Conclusion
In the present study, it was demonstrated that real-time
PCR with MCA is a sensitive and specific method for
the detection of clonally rearranged DNA on non
formalin-fixed and paraffin-embedded lymph node sam-
ples. The real-time PCR system combines amplification
reaction and subsequent assessment of clonal rearrange-
ment by MCA in the same instrument and reaction
vessel. This eliminates manual post-PCR processing
of the product and makes the method less labour- and
time-intensive than conventional PCR with PAGE.
Costs of materials for the real-time PCR are compar-
able those for the conventional system. Thus, the
real-time PCR method with MCA has the potential
for assisting the diagnosis of antigen receptor gene
rearrangement in canine lymphoma patients in a clinical
setting.
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